List view / Grid view
Evidence from a Phase I trial suggests that the tyrosine kinase inhibitor dasatinib in combination with quercetin clears amyloid from the brain and lowers inflammation in the blood.
The EMA’s Human Medicines Committee (CHMP) recommended approval of Paxlovid for COVID-19 and a new gene therapy for large B-cell lymphomas.
An NIH-funded study has demonstrated that a combination of senolytic drugs can successfully reverse cell senescence in mice; providing potential avenue for future age-related treatment study.
